Glaxo in for competition after Hikma’s generic asthma drug passes major milestone – Telegraph.co.uk


Telegraph.co.uk

Glaxo in for competition after Hikma's generic asthma drug passes major milestone
Telegraph.co.uk
Cheap versions of one of GlaxoSmithKline's top-selling asthma drugs could be available to patients as early as next year. Jordanian pharmaceuticals company Hikma moved one step closer to getting a generic version of Glaxo's Advair Diskus inhaler onto
Cipla's rival Hikma gets asthma drug nod in the USMoneycontrol.com
Vectura and Hikma's generic of Advair Diskus accepted for filing by US FDAThe Pharma Letter (registration)
Vectura Group PLC and Hikma shares given FDA boostProactive Investors UK

all 8 news articles »

View full post on asthma – Google News

Mylan sets sights on production of generic asthma inhaler – Tribune-Review


Yahoo News

Mylan sets sights on production of generic asthma inhaler
Tribune-Review
Besides providing a cheaper alternative for asthma sufferers across the country, being first to market with generic Advair is seen as key to Mylan's drive to boost growth and hit an ambitious earnings target of adjusted net income of at least $6 a
Mylan: Advair Generic Ready For LaunchBusiness Finance News

all 16 news articles »

View full post on asthma – Google News

Ajanta Pharma’s Generic Anti-Asthma Chewable Tablets Approved By US FDA – International Business Times


International Business Times

Ajanta Pharma's Generic Anti-Asthma Chewable Tablets Approved By US FDA
International Business Times
According to U.S. National Library of Medicine, Montelukast is used to prevent chest tightness, difficulty in breathing and wheezing and coughing caused by asthma. In addition, it is used to prevent the symptoms associated with seasonal allergies and
Ajanta Pharma launches generic asthma treatment tablets in USEconomic Times
Ajanta Pharma launches generic asthma treatment tabletsMoneycontrol.com
Ajanta Pharma launches anti-asthma tablets in USMyiris.com

all 17 news articles »

View full post on asthma – Google News

Ajanta Pharma launches generic asthma treatment tablets in US – Economic Times

Ajanta Pharma launches generic asthma treatment tablets in US
Economic Times
NEW DELHI: Ajanta Pharma has launched its generic Montelukast Sodium tablets used for treatment of asthma and seasonal allergies in the American market. Ajanta Pharma USA Inc, a subsidiary of the company today announced the launch of Montelukast …
Ajanta Pharma launches generic asthma treatment tabletsMoneycontrol.com
Ajanta Pharma launches anti-asthma tablets in USMyiris.com

all 7 news articles »

View full post on asthma – Google News

Ajanta Pharma launches generic asthma drug in US market – ETHealthWorld.com


ETHealthWorld.com

Ajanta Pharma launches generic asthma drug in US market
ETHealthWorld.com
New Delhi, Nov 16 : Ajanta Pharma today said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market. The company in a filing to BSE said Ajanta Pharma US Inc has launched montelucast sodium granules, …
Ajanta Pharma launches generic asthma drug in US market; shares up over 2%Daily News & Analysis

all 18 news articles »

View full post on asthma – Google News

Despite Generic Erosion of Current Market Leaders, the Asthma Market Will … – MarketWatch

Despite Generic Erosion of Current Market Leaders, the Asthma Market Will
MarketWatch
BURLINGTON, Mass., Sept. 22, 2015 /PRNewswire/ — Decision Resources Group finds that the market for asthma will remain relatively flat, increasing slightly from $15.9 billion in 2014 to $16.2 billion in 2024 across the seven major markets (the United

View full post on asthma – Google News

Jubilant Life gets USFDA nod for generic anti-asthma tablets – Economic Times

Jubilant Life gets USFDA nod for generic anti-asthma tablets
Economic Times
NEW DELHI: Drug firm Jubilant Life Sciences has received final approval from the US health regulator for generic Montelukast Sodium chewable tablets used in the treatment of asthma and to relieve symptoms of seasonal allergies. "The company has …
Jubilant Life Sciences gets ANDA nod for MontelukastMyiris.com

all 7 news articles »

View full post on asthma – Google News